(Q51620269)

8 April 2018

title

Exploring uncertainty in cost-effectiveness analysis. (English)

1 reference

8 April 2018

cost-effectiveness analysis

main subject

1 reference

1

Karl Claxton

1 reference

8 April 2018

publication date

1 January 2008

1 reference

8 April 2018

published in

PharmacoEconomics

1 reference

8 April 2018

volume

26

1 reference

8 April 2018

issue

9

1 reference

8 April 2018

page(s)

781-798

1 reference

8 April 2018

Incorporating option values into the economic evaluation of health care technologies

cites work

1 reference

12 December 2020

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

12 December 2020

Probabilistic analysis and computationally expensive models: Necessary and required?

1 reference

12 December 2020

Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis

1 reference

12 December 2020

Testing the validity of cost-effectiveness models

1 reference

12 December 2020

Expected value of sample information calculations in medical decision modeling.

1 reference

12 December 2020

Representing uncertainty: the role of cost-effectiveness acceptability curves

1 reference

12 December 2020

Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence

1 reference

12 December 2020

Expected value of information and decision making in HTA.

1 reference

12 December 2020

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

1 reference

12 December 2020

Sensitivity analysis and the expected value of perfect information

1 reference

12 December 2020

Subgroups and heterogeneity in cost-effectiveness analysis

1 reference

12 December 2020

Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.

1 reference

12 December 2020

The half-life of truth: what are appropriate time horizons for research decisions?

1 reference

12 December 2020

Truth survival in clinical research: an evidence-based requiem?

1 reference

12 December 2020

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

12 December 2020

Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses

1 reference

12 December 2020

Eliciting expert opinion for economic models: an applied example

1 reference

12 December 2020

Value of information literature analysis: a review of applications in health risk management.

1 reference

12 December 2020

Use of indirect and mixed treatment comparisons for technology assessment

1 reference

12 December 2020

On the (near) equivalence of cost-effectiveness and cost-benefit analyses

1 reference

12 December 2020

Eliciting and using expert opinions about dropout bias in randomized controlled trials

1 reference

12 December 2020

Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research.

1 reference

12 December 2020

The NICE cost-effectiveness threshold: what it is and what that means

1 reference

12 December 2020

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

12 December 2020

Value based pricing for NHS drugs: an opportunity not to be missed?

1 reference

12 December 2020

Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA

1 reference

12 December 2020

Expected value of sample information for Weibull survival data

1 reference

12 December 2020

An introduction to Markov modelling for economic evaluation

1 reference

12 December 2020

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

12 December 2020

Dimensions of design space: a decision-theoretic approach to optimal research design.

1 reference

12 December 2020

10.2165/00019053-200826090-00008

Identifiers

DOI

1 reference

8 April 2018

Dimensions Publication ID

1025352887

0 references

1 reference

8 April 2018